The effect of erythropoiesis-stimulating agents in patients with therapy-refractory autoimmune hemolytic anemia

Transfusion Medicine and Hemotherapy

Volumn 41, Issue 6, 2014, Pages 462-468

  Salama, Abdulgabar ^a   Hartnack, Dirk ^b   Lindemann, Hans Walter ^c   Lange, Hans Joachim ^d   Rummel, Mathias ^e   Loew, Andreas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Evangelisches Krankenhaus Wesel   (Germany)

^c Katholische Krankenhaus Hagen Gem GmbH   (Germany)

^d Gemeinschaftspraxis und Tagesklinik für Hämatologie und Internistische Onkologie   (Germany)

^e UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

AIHA; Autoimmune hemolytic anemia; EPO; Erythropoietin

Indexed keywords

ANTIANEMIC AGENT;

ADULT; AGED; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CLINICAL ARTICLE; DRUG EFFECT; DRUG RESPONSE; FEMALE; HUMAN; MALE; MIDDLE AGED; THERAPY REFRACTORY AUTOIMMUNE HEMOLYTIC ANEMIA; TREATMENT OUTCOME; VERY ELDERLY;

EID: 84918499551     PISSN: 16603796     EISSN: 16603818     Source Type: Journal    
DOI: 10.1159/000366244     Document Type: Article

References (27)

1. Dacie J: Auto-immune haemolytic anaemia (AIHA): warm antibody syndromes II: 'idiopathic' types: haematological and biochemical findings; in Dacie J (ed): The Haemolytic Anaemias, ed 3. Vol. 3. New York, Churchill Livingstone, 1992. pp 54-93.
2. Salama A, Ahrens N, Kiesewetter H: Serological and clinical aspects of autoimmune hemolytic anemias. Infus Ther Transfus Med 2002;29:206-217.
3. Petz LD, Garratty G: Immune Hemolytic Anemias, 2nd ed. Philadelphia, Churchill Livingstone 2004.
4. Allgood JW, Chaplin H Jr: Idiopathic acquired autoimmune hemolytic anemia. A review of fortyseven cases treated from 1955 through 1965. Am J Med 1967;43:254-273.
5. Murphy S, Lo Buglio AF: Drug therapy of autoimmune hemolytic anemia. Semin Hematol 1976;13:323-334.
6. King KE: Review: pharmacologic treatment of warm autoimmune hemolytic anemia. Immunohematology 2007;23:120-129.
7. Packman CH: Hemolytic anemia due to warm autoantibodies. Blood Rev 2008;22:17-31.
8. Lechner K, Jager U: How I treat autoimmune hemolytic anemias in adults. Blood 2010;116:1831-1838.
9. Crowther M, Chan YL, Garbett IK, Lim W, Vickers MA, Crowther MA: Evidence-based focused review of the treatment of idiopathic warm immune hemolytic anemia in adults. Blood 2011;118:4036-4040.
10. Michel M: Classification and therapeutic approaches in autoimmune hemolytic anemia: an update. Expert Rev Hematol 2011;4:607-618.
11. Arbach O, Funck R, Seibt F, Salama A: Erythropoietin may improve anemia in patients with autoimmune hemolytic anemia associated with reticulocytopenia. Transfus Med Hemother 2012;39:221-223.
12. Mayer B, Yürek S, Kiesewetter H, Salama A: Mixed-type autoimmune hemolytic anemia: differential diagnosis and a critical review of reported cases. Transfusion 2008;48:2229-2234.
13. Sinclair AM: Erythropoiesis stimulating agents: approaches to modulate activity. Biologics 2013;7:161-174.
14. Hernández JJ: Two cases of refractory autoimmune hemolytic anemia (AIHA) treated with Epoetin alpha (EPO). Haematologica 2007;92(suppl 2):533, abstract 1500.
15. Chadwick EG, Di Michele D, Yogev R: Characteristics of autoimmune hemolytic anemia (AIHA) in HIV-infected children. The Second National Conference on Human Retroviruses and Related Infections, Washington, D. C., January 1995..
16. Roque ME, Sandoval MJ, Aggio MC: Serum erythropoietin and its relation with soluble transferrin receptor in patients with different types of anaemia in a locally defined reference population. Clin Lab Haematol 2001;23:291-295.
17. Kuter DJ: Thrombopoietin and thrombopoietin mimetics in the treatment of thrombocytopenia. Annu Rev Med 2009;60:193-206.
18. Stasi R, Bosworth J, Rhodes E, Shannon MS, Willis F, Gordon-Smith EC: Thrombopoietic agents. Blood Rev 2010;24:179-190.
19. Hallam S, Provan D, Newland AC: Immune thrombocytopenia - what are the new treatment options? Expert Opin Biol Ther 2013;13:1173-1185.
20. Capsoni F, Sarzi-Puttini P, Zanella A: Primary and secondary autoimmune neutropenia. Arthritis Res Ther 2005;7:208-214.
21. Akhtari M, Curtis B, Waller EK: Autoimmune neutropenia in adults. Autoimmun Rev 2009;9:62-66.
22. Myssina S, Huber SM, Birka C, Lang PA, Lang KS, Friedrich B, Risler T, Wieder T, Lang F: Inhibition of erythrocyte cation channels by erythropoietin. J Am Soc Nephrol 2003;14:2750-2757.
23. Boas FE, Forman L, Beutler E: Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia. Proc Natl Acad Sci U S A 1998;95:3077-3081.
24. Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RA, Henson PM: A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 2000;405:85-90.
25. Kempe DS, Lang PA, Duranton C, Akel A, Lang KS, Huber SM, Wieder T, Lang F: Enhanced programmed cell death of iron-deficient erythrocytes. FASEB J 2006;20:368-370.
26. Lang E, Qadri SM, Lang F: Killing me softly - suicidal erythrocyte death. Int J Biochem Cell Biol 2012;44:1236-1243.
27. Iuchi Y, Kibe N, Tsunoda S, Suzuki S, Mikami T, Okada F, Uchida K, Fujii J: Implication of oxidative stress as a cause of autoimmune hemolytic anemia in NZB mice. Free Radic Biol Med 2010;48:935-944.